Andrew Burgon
Foot & Ankle Surgery · Farr West, UTNPI 1407296189
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (41.9%), travel and lodging and education — rather than concentrated in one kind of arrangement. 27 manufacturers reported payments, led by Stryker at 25.0% of the total. Reporting peaked in 2024 at $2,874 and has fallen 86.5% since, to $389 in 2025.
Across 106 payments — averaging $59.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$2K
- Active Medical, LLC$1K
- Paragon 28, Inc.$1K
- Treace Medical Concepts, Inc.$964
- Boston Scientific$143
- Fusion Orthopedics USA, LLC$108
- plus $825 from 21 others
What the payments were for
- Travel & lodging$2,44239%
- Food & beverage$2,62642%
- Education$1,20019%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker(2 entities) | 23 | $1,565 |
| Active Medical, LLC | 4 | $1,414 |
| Paragon 28, Inc. | 16 | $1,250 |
| Treace Medical Concepts, Inc. | 10 | $964 |
| Boston Scientific | 4 | $143 |
| Fusion Orthopedics USA, LLC | 1 | $108 |
| Anika Therapeutics, Inc. | 5 | $95 |
| Amgen | 6 | $84 |
| Orthofix Medical, Inc. | 6 | $78 |
| ANI Pharmaceuticals, Inc. | 3 | $74 |
| Paratek Pharmaceuticals, Inc. | 3 | $54 |
| Organogenesis Inc. | 3 | $51 |
| Mimedx Group, Inc. | 3 | $48 |
| Polynovo North America LLC | 2 | $43 |
| Kowa Pharmaceuticals America, Inc. | 2 | $39 |
| Smith+Nephew | 2 | $38 |
| AbbVie | 2 | $35 |
| Solventum Corporation | 1 | $26 |
| Integra Lifesciences Corporation | 2 | $25 |
| DJO, LLC | 1 | $24 |
| Nevro Corp. | 1 | $18 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $18 |
| Nalu Medical, Inc. | 1 | $17 |
| Axogen | 1 | $15 |
| KCI USA, Inc. | 1 | $15 |
| Arthrosurface Incorporated | 1 | $13 |
| Zyla Life Sciences, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lapiplasty System$860
- PROstep$797
- Portfolio$651
- Grappler$203
- N/A$175
How this compares
$6,268 in reported general payments places this provider in the 65th percentile of 104 foot & ankle surgery providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JubliaEfinaconazole | 26 | $19,852 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 48 | $1,172 |
| Meropenem | 14 | $895 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 43 | $297 |
| Gabapentin | 32 | $229 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 37 | $219 |
| Betamethasone Valerate | 13 | $201 |
| Mupirocin | 20 | $188 |
| Doxycycline Hyclate | 12 | $174 |
| Colchicine | 15 | $136 |
| Cephalexin | 18 | $134 |
| Silver Sulfadiazine | 14 | $100 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 12 | $98 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Ortho Dermatologics, A Division Of Bausch Health US, LLCJublia | $18 | $19,85226 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 104 foot & ankle surgery providers in Utah.
Other foot & ankle surgery in Farr West
- Gregory AndersonSalt Lake City$1.6M
- Ryan RigbyLogan$975K
- Florian NickischSalt Lake City$474K
- Brian LiljenquistSalt Lake City$263K
- Douglas TooleSalt Lake City$258K
- Francis ClarkWest Jordan$125K
- David SeegmillerSalt Lake City$120K
- Scott ClarkWest Jordan$74K
- Riley RamptonProvidence$49K
- Gregory CookLogan$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.